ACCORD HEALTHCARE SDN BHD — Ezetimibe Importer Profile
Pharmaceutical Importer · #18 buyer for Ezetimibe · $333.7K import value · 13 shipments · MALAYSIA · DGFT Verified
ACCORD HEALTHCARE SDN BHD is the #18 importer of Ezetimibe from India with $333.7K in import value and 13 verified shipments. ACCORD HEALTHCARE SDN BHD holds a 0.3% market share in Ezetimibe imports based in MALAYSIA. The company sources from 1 verified supplier across 4 formulations shipped to 1 country.
ACCORD HEALTHCARE SDN BHD — Ezetimibe Import Profile: Suppliers, Formulations & Sources
Who Actually Supplies Ezetimibe to ACCORD HEALTHCARE SDN BHD?
Verified from 13 customs shipment records
| Supplier | Value | Shipments | % Share |
|---|---|---|---|
| INTAS PHARMACEUTICALS LIMITED | $333.7K | 13 | 100.0% |
ACCORD HEALTHCARE SDN BHD sources Ezetimibe from 1 verified Indian supplier based on 13 customs records. The primary supplier is INTAS PHARMACEUTICALS LIMITED accounting for 100.0% of imports.
How Does ACCORD HEALTHCARE SDN BHD Compare to Nearest Ezetimibe Importers?
Buyers ranked immediately above and below #18 by import value
| # | Buyer | Country | Import Value | Shipments | Avg/Shipment |
|---|---|---|---|---|---|
| 12 | LEK D.D | SLOVENIA | $600.0K | 12 | $50.0K |
| 14 | CSP MYLAN SAS AT CSP LABO 274 | FRANCE | $600.0K | 12 | $50.0K |
| 18 | ACCORD HEALTHCARE SDN BHD ★ | MALAYSIA | $600.0K | 12 | $50.0K |
ACCORD HEALTHCARE SDN BHD ranks #18 among 466 Ezetimibe importers from India. Average shipment value of $50.0K compared to the market average of $112.5K. The closest competitors by value are LEK D.D and CSP MYLAN SAS AT CSP LABO 274.
Where Does ACCORD HEALTHCARE SDN BHD Import Ezetimibe To?
Destination countries from 13 verified shipments
| Country | Value | Shipments | Share |
|---|---|---|---|
| MALAYSIA | $333.7K | 13 | 100.0% |
ACCORD HEALTHCARE SDN BHD imports Ezetimibe to 1 country. The primary destination is MALAYSIA receiving 100.0% of shipments worth $333.7K.
What Ezetimibe Formulations Does ACCORD HEALTHCARE SDN BHD Import?
| Formulation | Value | Shipments |
|---|---|---|
| PHARMA DRUGS AND MEDI ACCORD EZETIMIBE 1 | $200.0K | 4 |
| PHARMA DRUGS AND MEDI ACCORD EZETIMIBE 10MG 3X10T(ACC-MAL) EZETIMIBE 10 MG AS PER INV | $50.0K | 1 |
| PHARMA DRUGS AND MEDI ACCORD EZETIMIBE 10MG 3X10TACC-MAL AS PER INV | $49.1K | 2 |
| PHARMA DRUGS AND MEDI ACCORD EZETIMIBE 10MG 3X10T AS PER INV | $34.6K | 6 |
ACCORD HEALTHCARE SDN BHD imports 4 distinct Ezetimibe formulations from India. The top formulation is PHARMA DRUGS AND MEDI ACCORD EZETIMIBE 1 with 4 shipments worth $200.0K.
Who Are the Top Buyers of Ezetimibe from India and How Much Does ACCORD HEALTHCARE SDN BHD Import?
India exported $52.4M worth of Ezetimibe through 5,033 shipments from 169 suppliers to 85 countries, serving 466 buyers globally. ACCORD HEALTHCARE SDN BHD imports $333.7K of this total, accounting for 0.3% of India's Ezetimibe exports with 13 shipments from MALAYSIA. This is verified from 13 customs shipment records covering 4 distinct formulations.
What Is the Average Order Value for ACCORD HEALTHCARE SDN BHD's Ezetimibe Imports?
ACCORD HEALTHCARE SDN BHD's average Ezetimibe order value is $25.7K per consignment, based on 13 shipments totaling $333.7K. ACCORD HEALTHCARE SDN BHD is based in MALAYSIA and ranks #18 among all Ezetimibe importers from India by value. The company sources from 1 verified supplier in India.
Who Supplies Ezetimibe to ACCORD HEALTHCARE SDN BHD?
ACCORD HEALTHCARE SDN BHD sources Ezetimibe from 1 verified Indian supplier: INTAS PHARMACEUTICALS LIMITED ($333.7K, 100.0%). This is based on 13 customs records.
How Does ACCORD HEALTHCARE SDN BHD Compare to Other Ezetimibe Importers?
ACCORD HEALTHCARE SDN BHD ranks #18 among 466 Ezetimibe importers from India with a 0.3% market share. The top 3 importers are BGP PRODUCTS GMBH ($16.4M), DAIICHI SANKYO EUROPE GMBH ($10.1M), ASCEND LABORATORIES,LLC ($6.7M). ACCORD HEALTHCARE SDN BHD processed 13 shipments from MALAYSIA.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Ezetimibe — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- European Medicines Agency
- WHO Essential Medicines
- Invest India — Pharma Sector
- India Trade Statistics (DGFT)
Verify import regulations and drug registration requirements with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Ezetimibe shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature and HS code classification.
- 2.Buyer Identification: ACCORD HEALTHCARE SDN BHD matched across shipments using first-3-word normalization of the consignee field, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort buyer rankings.
- 4.Market Share: Calculated as ACCORD HEALTHCARE SDN BHD's capped import value divided by total capped export value for Ezetimibe across all Indian exporters.
- 5.Verified Records: This page is backed by 13 individual customs records matching ACCORD HEALTHCARE SDN BHD importing Ezetimibe, covering 4 formulations from 1 verified supplier.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 85+ countries, 466+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Ezetimibe Import Data for ACCORD HEALTHCARE SDN BHD
Access order-level details, pricing data, supplier connections, and competitive analysis for ACCORD HEALTHCARE SDN BHD's Ezetimibe imports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
ACCORD HEALTHCARE SDN BHD
Company Profile
Multiple products · $0 total trade · Multiple categories
ACCORD HEALTHCARE SDN BHD × Ezetimibe
Verified from customs records
Related Analysis
Need Detailed Import Data?
Access shipment-level records, supplier contacts, and formulation details for ACCORD HEALTHCARE SDN BHD.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Ezetimibe. For current order-level data, contact TransData Nexus.